Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Clinical Trials01:16

Clinical Trials

9.8K
Clinical trials are prospective experimental studies conducted on humans to determine the safety and efficacy of treatments, drugs, diet methods, and medical devices. Using statistics in clinical trials enables researchers to derive reasonable and accurate conclusions from the collected data, allowing them to make wise decisions in uncertain situations. In medical research, statistical methods are crucial for preventing errors and bias.
There are four phases in a clinical trial. A phase one...
9.8K
Clinical Trials: Overview01:11

Clinical Trials: Overview

3.9K
Clinical development focuses on how the drug will interact with the human body and encompasses four key phases of clinical trials, each serving a specific purpose in assessing the safety and effectiveness of new drugs. These phases overlap and build upon one another. Phase I involves a small group of healthy volunteers (typically 20-80 individuals) or, in cases where significant toxicity is expected, patients with the targeted disease, such as cancer or AIDS. The volunteers are tested for...
3.9K
Hazard Ratio01:12

Hazard Ratio

300
The hazard ratio (HR) is a widely used measure in clinical trials to compare the risk of events, such as death or disease recurrence, between two groups over time. It reflects the ratio of hazard rates—the instantaneous risk of the event occurring—between a treatment group and a control group. This measure provides valuable insights into the relative effectiveness of a treatment by assessing how the risk of an event differs between the two groups.
For example, in a clinical trial...
300
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

207
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
207
Combination Therapies and Personalized Medicine02:50

Combination Therapies and Personalized Medicine

5.3K
Combining two or more treatment methods increases the life span of cancer patients while reducing damage to vital organs or tissue from the overuse of a single treatment. Combination therapy also targets different cancer-inducing pathways, thus reducing the chances of developing resistance to treatment.
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
5.3K
Preclinical Development: Overview01:28

Preclinical Development: Overview

5.3K
Preclinical development consists of a series of tests that ensure the safety and efficacy of a new therapeutic compound before it is tested in humans. There are four main phases to this process. First, safety pharmacology tests are conducted to ensure the drug does not produce any acutely harmful effects. These tests examine parameters such as bronchoconstriction, cardiac dysrhythmias, blood pressure changes, and ataxia. Next, preliminary toxicological testing is performed to determine the...
5.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

A Systematic Review and Meta-analysis of Ethnic Inequalities in Stroke Incidence Patterns and Trends in High-Income Countries (2015-2025).

Neuroepidemiology·2026
Same author

Variation in stroke survivors' long-term home care use: a South London population-based study.

European stroke journal·2026
Same author

Temporal Trends and Drivers of Socioeconomic Inequalities in Stroke Care, Survival, and Long-Term Outcomes.

Journal of the American Heart Association·2026
Same author

Reducing alcohol consumption in UK armed forces veterans: Feasibility of using personalized push notifications with AI.

PLOS digital health·2026
Same author

Ethnic Inequalities in Return to Work Post First Stroke: Findings From a Population-Based Cohort Study in South London.

Journal of the American Heart Association·2026
Same author

Implicitly and Differentiably Representing Protein Surfaces and Interfaces.

Pacific Symposium on Biocomputing. Pacific Symposium on Biocomputing·2026

Related Experiment Video

Updated: Oct 22, 2025

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.1K

Understanding Clinical Trial Reports: Extracting Medical Entities and Their Relations.

Benjamin E Nye1, Jay DeYoung1, Eric Lehman1

  • 1Northeastern University, Boston, MA.

AMIA Joint Summits on Translational Science Proceedings. AMIA Joint Summits on Translational Science
|August 30, 2021
PubMed
Summary
This summary is machine-generated.

This study introduces an automated system to extract treatment effectiveness data from clinical trial articles, speeding up drug repurposing for cancer treatment.

More Related Videos

Cloud-Based Phrase Mining and Analysis of User-Defined Phrase-Category Association in Biomedical Publications
09:20

Cloud-Based Phrase Mining and Analysis of User-Defined Phrase-Category Association in Biomedical Publications

Published on: February 23, 2019

8.9K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.9K

Related Experiment Videos

Last Updated: Oct 22, 2025

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts
07:50

A Metadata Extraction Approach for Clinical Case Reports to Enable Advanced Understanding of Biomedical Concepts

Published on: September 20, 2018

16.1K
Cloud-Based Phrase Mining and Analysis of User-Defined Phrase-Category Association in Biomedical Publications
09:20

Cloud-Based Phrase Mining and Analysis of User-Defined Phrase-Category Association in Biomedical Publications

Published on: February 23, 2019

8.9K
A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports
07:35

A Knowledge Graph Approach to Elucidate the Role of Organellar Pathways in Disease via Biomedical Reports

Published on: October 13, 2023

1.9K

Area of Science:

  • Biomedical Informatics
  • Natural Language Processing
  • Clinical Trials Research

Background:

  • Clinical trial results are crucial for treatment effectiveness evidence but are locked in unstructured text.
  • Manual extraction of this data is labor-intensive and costly.
  • Efficiently accessing this information is vital for medical decision-making and drug discovery.

Purpose of the Study:

  • To develop an end-to-end system for extracting treatments and outcomes from clinical trial articles.
  • To infer the comparative effectiveness of treatments based on extracted information.
  • To evaluate the system's utility in identifying potential drug repurposing candidates for cancer.

Main Methods:

  • Utilized Natural Language Processing (NLP) techniques for entity and relation extraction.
  • Introduced new datasets for training and evaluating the extraction models.
  • Developed a novel method inspired by typical trial result presentation, outperforming data-driven baselines.
  • Conducted a fielded evaluation with a non-profit organization.

Main Results:

  • The proposed method demonstrated superior performance compared to existing state-of-the-art NLP models.
  • The system successfully extracted treatments, outcomes, and their relationships from full-text articles.
  • The fielded evaluation confirmed the system's potential for identifying drugs for cancer repurposing.

Conclusions:

  • End-to-end evidence extraction systems can automate the retrieval of critical treatment effectiveness data.
  • This automation significantly accelerates the process of identifying potential drug repurposing opportunities.
  • The developed system shows promise for supporting medical research and drug development pipelines.